Good Phase 2 results of Covid-19 treatment

Allocetra from Israel’s Enlivex Therapeutics (reported here previously) has cured the majority of the 37 seriously and critically ill Covid-19 patients in its Phase 1b and 2 trials. 33 patients were discharged from hospital an average of under 6 days after treatment.

This entry was posted in Israel's Medical Achievements. Bookmark the permalink.

Leave a Reply

Your email address will not be published.